Warning! GuruFocus detected
2 Severe warning signs
with BHC.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Bausch Health Companies Inc
NAICS : 325412
SIC : 3741
ISIN : CA0717341071
Compare
Compare
Traded in other countries / regions
BHC.CanadaBHC.USABHC.MexicoBVF.GermanyVRX.Switzerland0QYW.UK IPO Date
1994-03-29Description
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.06 | |||||
| Equity-to-Asset | -0.05 | |||||
| Debt-to-Equity | -16.9 | |||||
| Debt-to-EBITDA | 7.91 | |||||
| Interest Coverage | 1.34 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 0.03 | |||||
| Beneish M-Score | -2.6 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.4 | |||||
| 3-Year EBITDA Growth Rate | 16.2 | |||||
| 3-Year EPS without NRI Growth Rate | 26.4 | |||||
| 3-Year FCF Growth Rate | 6.1 | |||||
| 3-Year Book Growth Rate | -135.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 94.97 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 3.28 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 70.91 | |||||
| 9-Day RSI | 59.62 | |||||
| 14-Day RSI | 54.86 | |||||
| 3-1 Month Momentum % | -4.78 | |||||
| 6-1 Month Momentum % | -11.26 | |||||
| 12-1 Month Momentum % | -25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.86 | |||||
| Quick Ratio | 0.62 | |||||
| Cash Ratio | 0.17 | |||||
| Days Inventory | 209.83 | |||||
| Days Sales Outstanding | 78.32 | |||||
| Days Payable | 85.1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.8 | |||||
| Shareholder Yield % | -23.67 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 71.1 | |||||
| Operating Margin % | 19.35 | |||||
| Net Margin % | -0.42 | |||||
| FCF Margin % | 13.06 | |||||
| ROA % | -0.15 | |||||
| ROIC % | -2.95 | |||||
| 3-Year ROIIC % | -222.96 | |||||
| ROC (Joel Greenblatt) % | 64.89 | |||||
| ROCE % | 7.18 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 1.61 | |||||
| PE Ratio without NRI | 11.25 | |||||
| Price-to-Owner-Earnings | 2.65 | |||||
| PEG Ratio | 1.56 | |||||
| PS Ratio | 0.28 | |||||
| Price-to-Free-Cash-Flow | 2.17 | |||||
| Price-to-Operating-Cash-Flow | 1.73 | |||||
| EV-to-EBIT | 15.45 | |||||
| EV-to-Forward-EBIT | 12.69 | |||||
| EV-to-EBITDA | 8.51 | |||||
| EV-to-Forward-EBITDA | 6.38 | |||||
| EV-to-Revenue | 2.5 | |||||
| EV-to-Forward-Revenue | 2.3 | |||||
| EV-to-FCF | 19.73 | |||||
| Price-to-GF-Value | 0.85 | |||||
| Price-to-Projected-FCF | 0.54 | |||||
| Price-to-Median-PS-Value | 0.38 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.15 | |||||
| Earnings Yield (Greenblatt) % | 6.47 | |||||
| FCF Yield % | 47.02 | |||||
| Forward Rate of Return (Yacktman) % | 32.82 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:BHC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bausch Health Companies Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 9,625 | ||
| EPS (TTM) ($) | -0.12 | ||
| Beta | 0.02 | ||
| 3-Year Sharpe Ratio | -0.31 | ||
| 3-Year Sortino Ratio | -0.4 | ||
| Volatility % | 57.72 | ||
| 14-Day RSI | 54.86 | ||
| 14-Day ATR ($) | 0.267039 | ||
| 20-Day SMA ($) | 7.173 | ||
| 12-1 Month Momentum % | -25 | ||
| 52-Week Range ($) | 3.96 - 11.46 | ||
| Shares Outstanding (Mil) | 367.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bausch Health Companies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bausch Health Companies Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bausch Health Companies Inc Frequently Asked Questions
What is Bausch Health Companies Inc(BHC)'s stock price today?
The current price of BHC is $7.27. The 52 week high of BHC is $11.46 and 52 week low is $3.96.
When is next earnings date of Bausch Health Companies Inc(BHC)?
The next earnings date of Bausch Health Companies Inc(BHC) is 2025-05-02 Est..
Does Bausch Health Companies Inc(BHC) pay dividends? If so, how much?
Bausch Health Companies Inc(BHC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers